CTRI/2025/12/099038尚未招募4 期
Comparison of efficacy of 3 months Isoniazid Rifampicin versus 3 months Isoniazid Rifapentine therapy for children suffering from Tuberculosis Infection A Randomised Open Label Controlled trial
Sayed Bilal Abbas Rizvi1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2025年12月31日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 128
- 试验地点
- 1
研究概览
简要总结
After fulfilling the inclusion and exclusion criteria 128 patient will be selected and then they will be randomised by computer generated random table and allotment and concealment of subject will be done by using snose technique and then one group will recieve Isoniazid Rifampicin and the other group will recieve Isoniazid Rifapentine and then we will compare the efficacy of the two drug and compare compliance rate of the two combination medications in these children and compare adverse drug reactions the two combination medications in these children.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant and Investigator Blinded
入排标准
- 年龄范围
- 2.00 Year(s) 至 18.00 Year(s)（—）
- 性别
- All
入选标准
- •children of 2 years to less than 18years of both gendder who are contact of adult pulmonary TB patient who have TB infection.
排除标准
- •Children who are tuberculosis positive.
- •Children who are on steriod therapy(in last 2months).
- •Children who are chronically ill(nephrotyic syndrome, asthma, chronic diarrhea).
研究者
Sayed Bilal Abbas Rizvi
Era Medical College
研究点 (1)
Loading locations...
相似试验
招募中
4 期
Comparison of three short rifamycin-based regimens to treat latent tuberculosis in patients with end-stage kidney disease.2023-506432-32-00Bellvitge University Hospital, Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL225
招募中
2 期
A study with three treatments for higher-risk chronic myelomonocytic leukaemia.chronic myelomonocytic Leukemia2024-511102-22-00GCP-Service International West GmbH30
尚未招募
3 期
Comparative Clinical Study To Evaluate The Efficacy Of Tila Kwatha Gandusha And Triphala (Bibhitaki Aamlaki Haritaki) Kwatha Gandusha In Mukhapaka With Special Reference To StomatitisCTRI/2025/09/094012Dr Tejaswini Suresh Makode60
招募中
3 期
CPAAARI-Therapeutic efficacy comparison of a six-month treatment by itraconazole and nebulised Ambisome® versus treatment by itraconazole alone in non- or mildly- immunocompromised patients with Chronic Pulmonary Aspergillosis: a prospective, randomized, single blind study, (single aspergilloma excluded).2024-517004-11-00Centre Hospitalier Universitaire De Poitiers224
招募中
不适用
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast CancerMetastatic Breast CancerNCT07347600Hoffmann-La Roche500